TomoWave Laboratories, Inc.

TomoWave Laboratories, Inc. is a vertically integrated company focused on developing and commercializing innovative technologies for optoacoustic tomography (OAT), imaging, sensing, and monitoring in biomedical applications. With a mission to produce groundbreaking biomedical solutions, the company's strong team is dedicated to taking ideas from early-stage research to manufacturing and regulatory certification. The company recently launched its first commercial product, the Laser Optoacoustic Imaging System (LOIS-3D) for preclinical research in small laboratory animals. Additionally, their clinical system, LOUISA-3D, designed for breast cancer detection in dense breasts and quantitative diagnostic imaging, is currently undergoing clinical validation at the University of Texas MD Anderson Cancer Center. Founded in 2010 and headquartered in the United States, TomoWave Laboratories offers customizable system components including analog and digital electronics and software to address unique optoacoustic imaging needs in the biotechnology and healthcare industries.